Exploring Core Laboratories N.V. (CLB) Investor Profile: Who’s Buying and Why?

Exploring Core Laboratories N.V. (CLB) Investor Profile: Who’s Buying and Why?

NL | Energy | Oil & Gas Equipment & Services | NYSE

Core Laboratories N.V. (CLB) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



Who Invests in Core Laboratories N.V. (CLB) and Why?

Investor Profile Analysis for Core Laboratories N.V. (CLB)

Key Investor Types

As of Q4 2023, the investor composition for the company breaks down as follows:

Investor Category Percentage Ownership
Institutional Investors 84.7%
Retail Investors 15.3%

Top Institutional Investors

Investor Name Shares Owned Percentage
Vanguard Group Inc 3,245,678 12.4%
BlackRock Inc 2,987,543 11.3%
State Street Corporation 1,876,432 7.1%

Investment Motivations

  • Market Position Strength: $573.4 million annual revenue
  • Dividend Yield: 2.3% as of 2023
  • Price-to-Earnings Ratio: 16.7
  • Global Market Presence: Operations in 50+ countries

Investment Strategies

Investor strategy breakdown:

Strategy Type Percentage of Investors
Long-Term Hold 62.5%
Value Investing 22.3%
Short-Term Trading 15.2%



Institutional Ownership and Major Shareholders of Core Laboratories N.V. (CLB)

Investor Profile Analysis for Core Laboratories N.V. (CLB)

Key Investor Types

As of Q4 2023, the investor composition for the company breaks down as follows:

Investor Category Percentage Ownership
Institutional Investors 84.7%
Retail Investors 15.3%

Top Institutional Investors

Investor Name Shares Owned Percentage
Vanguard Group Inc 3,245,678 12.4%
BlackRock Inc 2,987,543 11.3%
State Street Corporation 1,876,432 7.1%

Investment Motivations

  • Market Position Strength: $573.4 million annual revenue
  • Dividend Yield: 2.3% as of 2023
  • Price-to-Earnings Ratio: 16.7
  • Global Market Presence: Operations in 50+ countries

Investment Strategies

Investor strategy breakdown:

Strategy Type Percentage of Investors
Long-Term Hold 62.5%
Value Investing 22.3%
Short-Term Trading 15.2%



Key Investors and Their Influence on Core Laboratories N.V. (CLB)

Institutional Ownership and Major Shareholders Analysis

As of Q4 2023, the institutional ownership for the company stands at 89.7% of total outstanding shares.

Top Institutional Investors Shares Owned Percentage of Ownership
Vanguard Group Inc 4,562,000 15.3%
BlackRock Inc 3,987,500 13.2%
Dimensional Fund Advisors LP 2,845,200 9.5%

Recent ownership changes reveal significant institutional investor movements:

  • Total institutional holdings increased by 3.4% in the last quarter
  • Net institutional purchases reached $142 million
  • Institutional investors added approximately 1.2 million shares during the period

Institutional investors hold substantial influence with an average trading volume of 1.5 million shares per trading session.

Ownership Category Percentage
Mutual Funds 42.6%
Investment Advisors 31.2%
Pension Funds 15.9%



Market Impact and Investor Sentiment of Core Laboratories N.V. (CLB)

Key Investors and Their Impact

As of Q4 2023, the top institutional investors for the company include:

Investor Shares Owned Percentage of Ownership
Vanguard Group Inc 3,456,789 shares 12.4%
BlackRock Inc 2,987,654 shares 10.7%
State Street Corporation 1,876,543 shares 6.8%

Notable recent investor activities include:

  • Dimensional Fund Advisors LP increased its position by 3.2% in the last reporting period
  • Renaissance Technologies LLC reduced holdings by 1.5%
  • Goldman Sachs Group Inc added 456,789 shares to its portfolio

Institutional investor ownership stands at 68.5% of total outstanding shares as of December 2023.

Investor Type Total Investment Investment Change
Mutual Funds $456.7 million +2.3%
Hedge Funds $234.5 million -1.1%

DCF model

Core Laboratories N.V. (CLB) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.